Dexamethasone delivery to posterior segment of the eye

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 57, Issue 1-4, 2007, Pages 585-589

  Loftsson, Thorsteinn ^a   Sigurdsson, Hákon H ^a   Hreinsdóttir, Dagný ^a   Konrádsdóttir, Fífa ^a   Stefánsson, Einar ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Cyclodextrin; Eye drops; Ophthalmic drug delivery; Steroid; Topical

Indexed keywords

EID: 34047096267     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-006-9253-4     Document Type: Conference Paper

References (25)

1. Ahmed, I., Gokhale, R.D., Shah, M.V., Patton, T.F.: Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. J. Pharm. Sci. 76, 583-586 (1987)
2. Wang, W., Sasaki, H., Chien, D.-S., Lee, V.H.L.: Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr. Eye Res. 10, 571-579 (1991)
3. Loftsson, T., Stefánsson, E.: Effect of cyclodextrins on topical drug delivery to the eye. Drug Devel. Ind. Pharm. 23, 473-481 (1997)
4. Loftsson, T., Stefánsson, E.: Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol. Scand. 80, 144-150 (2002)
5. Chrai, S.S., Patton, T.F., Mehta, A., Robinson, J.R.: Lacrimal and instilled fluid dynamics in rabbit eye. J. Pharm. Sci. 62, 1112-1121 (1973)
6. Gangrade, N.K., Gaddipati, N.B., Ganesan, M.G., Reddy, I.K.: Topical ophthalmic formulations: basic considerations. In: Reddy, I.K. (ed.) Ocular Therapeutics and Drug Delivery, pp. 377-403. Technomic Publications, Lancaster (1996)
7. Loftsson, T., Järvinen, T.: Cyclodextrins in ophthalmic drug delivery. Adv. Drug Deliv. Rev. 36, 59-79 (1999)
8. Washington, N., Washington, C., Wilson, C.G.: Ocular drug delivery. Physiological pharmaceutics: barriers to drug absorption, pp. 249-270. Taylor and Francis, London (2001)
9. Myles, M.E., Neumann, D.M., Hill, J.M.: Recent progress in ocular drug delivery for posterior segment disease: emphasis on transsclera iontophoresis. Adv. Drug Deliv. Rev. 57, 2063-2079 (2005)
10. Raghava, S., Hammond, M., Kompella, U.B.: Periocular routes for retinal drug delivery. Exp. Opin. Drug Deliv. 1, 99-114 (2004)
11. Yasukawa, T., Ogura, Y., Sakurai, E., Tabata, Y., Kimura, H.: Intraocular sustained drug delivery using implantable polymer devices. Adv. Drug Deliv. Rev. 57, 2033-2047 (2005)
12. Jonas, J.B.: Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol. Scand. 83, 645-663 (2005)
13. Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J.: Experimental and computatorial approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3-26 (2001)
14. Amidon, G.L., Lennernäs, H., Shah, V.P., Crison, J.R.: A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12, 413-420 (1995)
15. Loftsson, T., Masson, M.: Cyclodextrins in topical drug formulations: theory and practice. Int. J. Pharm. 225, 15-30 (2001)
16. Sinha, V.R., Bindra, S., Kumria, R., Nanda, A.: Cyclodextrin as skin-penetration enhancers. Pharm. Technol. 27(3), 120-138 (2003)
17. Loftsson, T., Konráǒsdóttir, F., Másson, M.: Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Pharmazie 61, 83-89 (2006)
18. Loftsson, T., Sigfússon, S.D., Sigurosson, H.H., Másson, M.: The effects of cyclodextrins on topical delivery of hydrocortisone: the aqueous diffusion layer. S.T.P. Pharma Sci. 13, 125-131 (2003)
19. Merkus, F.W.H.M., Verhoef, J.C., Marttin, E., Romeijn, S.G., van der Kuy, P.H.M., Hermens, W.A.J.J., Schipper, N.G.M.: Cyclodextrin in nasal drug delivery. Adv. Drug Deliv. Rev. 36, 41-57 (1999)
20. Yang, T., Hussain, A., Paulson, J., Abbruscato, T.J., Ahsan, F.: Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies. Pharm. Res. 21, 1127-1136 (2004)
21. Loftsson, T., Fridriksdottir, H., Thorisdottir, S., Stefansson, E.: The effect of hydroxypropyl methylcellulose on release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations. Int. J. Pharm. 104:181-184 (1994)
22. Loftsson, T., Hreinsdóttir, D., Másson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18-28 (2005)
23. Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965)
24. Weijtens, O., Feron, E.J., Schoemaker, R.C., Cohen, A.F., Lentjes, E.G.W.M., Romijn, F.P.H.T.M., van Meurs, J.C.: High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am. J. Ophthalmol. 128, 192-197 (1999)
25. Shiah, J.-G., Bhagat, R., Nivaggioli, T., Peng, L., Chou, D., Weber, D.A.: Ocular implant made by a double extrusion process. US Patent Application No.: 2005/0048099, Allergan Inc. 3 March 2005, USA